- Home
- SSKN vs NDRA Comparison
SSKN vs NDRA Comparison
Compare SSKN & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSKN
- NDRA
- Stock Information
- Founded
- SSKN 1989
- NDRA 2007
- Country
- SSKN United States
- NDRA United States
- Employees
- SSKN N/A
- NDRA N/A
- Industry
- SSKN Medical/Dental Instruments
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SSKN Health Care
- NDRA Health Care
- Exchange
- SSKN Nasdaq
- NDRA Nasdaq
- Market Cap
- SSKN 8.9M
- NDRA 7.3M
- IPO Year
- SSKN 2005
- NDRA 2017
- Fundamental
- Price
- SSKN $1.65
- NDRA $6.30
- Analyst Decision
- SSKN Strong Buy
- NDRA Strong Buy
- Analyst Count
- SSKN 1
- NDRA 1
- Target Price
- SSKN $6.00
- NDRA $38.00
- AVG Volume (30 Days)
- SSKN 1.6M
- NDRA 91.5K
- Earning Date
- SSKN 11-13-2025
- NDRA 11-14-2025
- Dividend Yield
- SSKN N/A
- NDRA N/A
- EPS Growth
- SSKN N/A
- NDRA N/A
- EPS
- SSKN N/A
- NDRA N/A
- Revenue
- SSKN $32,848,000.00
- NDRA N/A
- Revenue This Year
- SSKN N/A
- NDRA N/A
- Revenue Next Year
- SSKN $9.70
- NDRA N/A
- P/E Ratio
- SSKN N/A
- NDRA N/A
- Revenue Growth
- SSKN 0.36
- NDRA N/A
- 52 Week Low
- SSKN $1.38
- NDRA $2.90
- 52 Week High
- SSKN $3.86
- NDRA $11.96
- Technical
- Relative Strength Index (RSI)
- SSKN 46.31
- NDRA 58.16
- Support Level
- SSKN $1.54
- NDRA $4.99
- Resistance Level
- SSKN $1.73
- NDRA $5.99
- Average True Range (ATR)
- SSKN 0.17
- NDRA 0.52
- MACD
- SSKN -0.00
- NDRA 0.05
- Stochastic Oscillator
- SSKN 18.67
- NDRA 70.33
About SSKN Strata Skin Sciences Inc.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.